The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rethinking breast cancer surveillance in women with BRCA-associated ovarian cancer in the post-solo trial era.
 
Catherine S. John
No Relationships to Disclose
 
Farin F. Amersi
No Relationships to Disclose
 
Abigail Fong
No Relationships to Disclose
 
Jessica Gillen
No Relationships to Disclose
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; Aravive; AstraZeneca; Clovis Oncology; Genentech/Roche; Immunogen; Janssen Oncology; Merck; OncoMed; Pfizer/EMD Serono; Samumed; TESARO; VBL Therapeutics
Speakers' Bureau - AstraZeneca
Research Funding - Abbvie/Stemcentrx (Inst); Advaxis (Inst); Agenus (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Forty Seven (Inst); Genentech (Inst); Immunogen (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Novogen (Inst); PTC Therapeutics (Inst); Regeneron (Inst); Stem CentRx (Inst); Takeda (Inst); Tesaro (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
Other Relationship - AstraZeneca
 
Christine S. Walsh
Consulting or Advisory Role - Alexion Pharmaceuticals; AstraZeneca; Clovis Oncology
Research Funding - Merck
Travel, Accommodations, Expenses - Intuitive Surgical
 
Andrew John Li
No Relationships to Disclose
 
Bj Rimel
Honoraria - Genentech
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Tesaro
 
Ilana Cass
No Relationships to Disclose